Importance of the progestogen added to the estrogen in hormone therapy

C Lauritzen. Climacteric. 2005 Dec.

. 2005 Dec;8(4):398-400.

doi: 10.1080/13697130500345091.

No abstract available

Similar articles

[Treatment with estrogen].
Ingelman-Sundberg A. Ingelman-Sundberg A. Lakartidningen. 2002 Nov 21;99(47):4777-8. Lakartidningen. 2002. PMID: 12523062 Swedish. No abstract available.
What pharmacists need to know about the women's health initiative estrogen plus progestin trial.
Saseen JJ, Hansen LB. Saseen JJ, et al. Am J Health Syst Pharm. 2003 Feb 1;60(3):281-4. doi: 10.1093/ajhp/60.3.281. Am J Health Syst Pharm. 2003. PMID: 12613239 No abstract available.
Hormone replacement therapy and risk of heart disease.
Elliott KK. Elliott KK. Am Fam Physician. 1999 Nov 15;60(8):2234, 2237. Am Fam Physician. 1999. PMID: 10593314 No abstract available.
Lower doses of estrogen replacement therapy and the risk of cardiovascular disease.
Wakatsuki A. Wakatsuki A. Arterioscler Thromb Vasc Biol. 2004 Dec;24(12):e197; author reply e197. doi: 10.1161/01.ATV.0000148203.03346.b5. Arterioscler Thromb Vasc Biol. 2004. PMID: 15576640 Review. No abstract available.
Changes in postmenopausal hormone therapy use since 1988.
Kim JK, Alley D, Hu P, Karlamangla A, Seeman T, Crimmins EM. Kim JK, et al. Womens Health Issues. 2007 Nov-Dec;17(6):338-41. doi: 10.1016/j.whi.2007.05.001. Epub 2007 Oct 22. Womens Health Issues. 2007. PMID: 17936641 Free PMC article. Review. No abstract available.